West Pharmaceutical Services, Inc. (WST)
Market Closed
1 Sep, 20:00
$
338. 65
-2.46
-0.7212%
$
23.75B Market Cap
49.01 P/E Ratio
0.88% Div Yield
441,745 Volume
7.62 Eps
$ 341.11
Previous Close Want to track WST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
WST closed today lower at $338.65, a decrease of -0.7212% from yesterday's close, completing a monthly decrease of -1.475% or -$5.07. Over the past 12 months, WST stock gained 23.0336%.
WST pays dividends to its shareholders, with the most recent payment made on Aug 05, 2026. The next estimated payment will be in In 2 months on Nov 05, 2026 for a total of $0.22.
The last earnings report, released on Apr 23, 2026, missed the consensus estimates by -1.68%. On average, the company has fell short of earnings expectations by -0.3967%, based on the last three reports.
West Pharmaceutical Services, Inc. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).
WST Chart
People also search for
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?
West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.
Zacks | 2 weeks ago
West Pharmaceutical (WST) Upgraded to Buy: Here's Why
West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 2 weeks ago
Should Investors Buy WST as HVP Growth Meets a Premium Valuation?
WST's faster HVP growth, wider margins and stronger earnings outlook support the bull case, but its premium valuation leaves less room for error.
Zacks | 2 weeks ago
West Pharmaceutical Services, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 660 | $237,077 | $229,640.4 | -$7,436.6 | -3.14% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 100 | $39,571 | $34,096 | -$5,475 | -13.84% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 671 | $240,000 | $228,784.15 | -$11,215.85 | -4.67% |
 Curtis Ellergodt Rothschild Investment LLC | 90 | $23,865.91 | $31,314.6 | $7,448.69 | 31.21% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 2,471 | $886,951 | $874,906.99 | -$12,044.01 | -1.36% |
West Pharmaceutical Services, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Paul Knight Keybanc | 31.95 | $11,683.66 | $10,777.05 | -$906.61 | -7.76% |
West Pharmaceutical Services, Inc. (WST) FAQ
What is the stock price today?
The current price is $338.65.
On which exchange is it traded?
West Pharmaceutical Services, Inc. is listed on NYSE.
What is its stock symbol?
The ticker symbol is WST.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.88%.
What is its market cap?
As of today, the market cap is 23.75B.
Has West Pharmaceutical Services, Inc. ever had a stock split?
West Pharmaceutical Services, Inc. had 4 splits and the recent split was on Sep 27, 2013.
West Pharmaceutical Services, Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Eric Green CEO | NYSE Exchange | 955306105 CUSIP |
| US Country | 10,800 Employees | 29 Jul 2026 Last Dividend | 27 Sep 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
West Pharmaceutical Services, Inc. is a leading global provider in the design, manufacturing, and sale of containment and delivery systems for injectable drugs and healthcare products. With a presence across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, the company operates through two primary segments: Proprietary Products and Contract-Manufactured Products. Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services, Inc. is dedicated to serving biologic, generic, and pharmaceutical drug companies, as well as pharmaceutical, diagnostic, and medical device companies through a comprehensive sales force, distribution network, contract sales agents, and regional distributors.
Products and Services
- Stoppers and Seals for Injectable Packaging Systems: These are designed for use in vials and other packaging systems to ensure the integrity and sterility of injectable drugs.
- Syringe and Cartridge Components: This includes custom solutions for injectable drug applications, offering enhanced safety and efficiency in drug delivery through advanced technologies in reconstitution, mixing, and transfer.
- Films, Coatings, Washing, Vision Inspection, and Sterilization Services: These services aim to improve the quality of packaging components, ensuring that they meet stringent healthcare standards.
- Drug Containment Solutions: Among their offerings is Crystal Zenith, a high-performance cyclic olefin polymer used in formulating vials, syringes, and cartridges. This product line is geared towards providing superior containment solutions for sensitive biologics and other pharmaceuticals.
- Self-Injection Devices: These devices are designed to facilitate self-administration of drugs, improving patient compliance and convenience. West also offers a variety of integrated services such as analytical lab services, pre-approval primary packaging support, engineering development, regulatory expertise, and after-sales technical support to complement these offerings.
- Design, Manufacture, and Automated Assembly of Devices: Within their Contract-Manufactured Products segment, the focus is on creating devices for surgical, diagnostic, ophthalmic, injectable, and various drug delivery systems, as well as consumer products. This entails a close collaboration with pharmaceutical, diagnostic, and medical device companies to develop solutions that meet specific requirements.
Contact Information
Address: 530 Herman O. West Drive
Phone: 610 594 2900
Website: https://www.westpharma.com
